Clear Cell Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Clear Cell Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial comparing MLN0128 (and MLN0128 + MLN1117) vs everolimus in adults with advanced or metastatic clear-cell renal cell carcinoma;…
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma: [Phase 1, Phase 2]
Phase Ib/Phase II study updates for MK-3475 in combination for clear cell renal cell carcinoma have completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 study evaluating a PD-1 inhibitor in combination with autologous cell immunotherapy for metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma [Phase 1, Phase 2]
Phase I/II trial evaluating RAD001 (everolimus) with hydroxychloroquine in previously treated metastatic clear cell renal cell carcinoma; st…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors [Phase 2]
A phase 2 clinical trial evaluating axitinib in metastatic renal cell carcinoma with favorable prognostic factors has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib [Phase 2]
Phase 2 biomarker study investigating metastatic clear cell renal cell carcinoma patients treated sequentially with first-line sunitinib and…
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) [Phase 1]
Phase 1 trial evaluating nivolumab in combination with sunitinib, pazopanib, or ipilimumab in metastatic renal cell carcinoma has completed …
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial of LY2510924 plus sunitinib in metastatic clear cell renal cell carcinoma was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Diagnostic Imaging for Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial update on diagnostic imaging for clear cell renal cell carcinoma has been terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy [Phase 3]
A Phase 3 trial evaluating everolimus with or without bevacizumab in advanced kidney cancer that progressed after first-line therapy was ter…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer [Phase 2]
Phase 2 trial comparing cabozantinib-s-malate versus sunitinib in untreated locally advanced or metastatic kidney cancer completed with resu…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery [Phase 3]
Phase 3 trial investigating targeted therapy with or without nephrectomy in metastatic clear-cell renal cell carcinoma; study terminated.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer [Phase 2]
Phase 2 trial evaluating pazopanib hydrochloride given before surgery in patients with renal cell carcinoma has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update of sunitinib malate in patients with previously untreated metastatic clear cell renal cell carcinoma (stage IV) has com…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma [Phase 1]
A Phase 1 study evaluating varlilumab (anti-CD27) in combination with sunitinib for metastatic clear-cell renal cell carcinoma has been term…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with or without TRC105 in metastatic kidney cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma [Phase 2]
Phase 2 study evaluating IMO-2055 for metastatic or locally recurrent clear cell renal cell carcinoma has completed and results are posted.
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule [Phase 2]
This Phase 2 trial evaluated the efficacy and safety of an individualized dosing schedule of sunitinib in patients with metastatic clear cel…
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors [Phase 1]
Phase 1 trial of sunitinib malate in adults with unresectable or metastatic kidney cancer and other advanced solid tumors. The study status …
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma [Phase 4]
A Phase 4 clinical trial update reports completion of a study evaluating first-line pazopanib in poor-risk patients with metastatic renal ce…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy, radiation therapy, and/or surgery for high-risk pediatric kidney tumors; results…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer [NA]
A terminated clinical trial used dynamic contrast-enhanced MRI to measure the effects of pazopanib in metastatic kidney cancer, with results…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma [Phase 1, Phase 2]
Clinical trial update for BNC105P combined with everolimus in progressive metastatic clear cell renal cell carcinoma; phases 1 and 2 complet…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate [Phase 1, Phase 2]
Phase 1/2 trial investigating panobinostat and everolimus in metastatic or unresectable renal cell cancer after failure of sunitinib or sora…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy [Phase 2]
Phase 2 trial evaluating RO4929097 in patients with advanced renal cell carcinoma after VEGF/VEGFR therapy has completed with results posted…